SEC Form 4 · accession 0001193125-26-296504
BridgeBio Oncology Therapeutics, Inc. · BBOT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Cobo
Officer — Principal Accounting Officer
Period of report
Jul 1, 2026
Accepted (ET)
Jul 6, 2026 · 6:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001869105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 1, 2026 | F | 125 | $7.80 | D | 5,306 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.